发布时间：2019年7月23日
新特性
此版本的变化包括安全优化（包括安全问题修复），一些性能优化和缺陷修复。
在新特性方面，你可以根据用户停留时间创建目标。这样，你就可以根据此目标创建筛选条件，进而把停留时长超过特定时间的用户筛选出来了。
在安全优化方面，此版本可以对密码重置频繁度进行限制，以防止大量垃圾重置邮件的出现。避免密码被错误重置成弱密码。如果密码长度小于特定长度，用户会被强制要求修改。在matomo后台的操作界面或者报告中，如果点击报告中的某个网址，目标网站就会知道你的matomo的服务器地址。此版本添加了一个新特性就是在从matomo后台点击跳转到其他网站时携带了Referrer-Policy，它可以控制在目标网页无法获取到referre信息。
此版本还进行了一些性能优化，某些matomo请求的响应时间比之前版本快10%。在随后的版本，我们还会持续优化。如果你的matomo数据库实现了读写分离的话，此版本可以轻松完成配置，这样会大大降低主服务器的CPU使用率，进而提高数据上报请求的相应速度（请参见global.ini.php的[database_reader]配置章节）。
在用户界面上，我们做了微调，比如网站列表的下拉菜单变宽了，网站名可以显示全了。
此版本还修复了一些bug，比如UI，追踪接口，双因子兼容性，报表嵌入，归档器等。
安全发布
此版本很重要
数据库更新
此版本不涉及主要的的数据库更新
平台更新
在此3.11.0版本，接口方面没有变化。
I got this website from my friend who informed me regarding this
site and at the moment this time I am visiting this website
and reading very informative articles at this time.
Its not my first time to go to see this site, i am browsing this website dailly and get fastidious data from here all the time.
You really make it seem so easy with your presentation but I find this matter to be actually something that I think I would never understand.
It seems too complicated and very broad for me. I am looking forward
for your next post, I’ll try to get the hang of it!
Wow, this post is pleasant, my sister is analyzing such things, thus
I am going to inform her.
Your point of view caught my eye and was very interesting. Thanks. I have a question for you.
Hello, I enjoy reading through your article.
I like to write a little comment to support you.
I am sure this article has touched all the internet viewers, its
really really good piece of writing on building up new
website.
Hello, Neat post. There is a problem together with
your site in internet explorer, might test this?
IE nonetheless is the market leader and a good portion of people will omit your wonderful writing due to this problem.
You really make it seem so easy with your presentation but I find
this matter to be actually something that I think I would never understand.
It seems too complex and very broad for me.
I’m looking forward for your next post, I will try to get
the hang of it!
Great post. I was checking constantly this blog and
I am impressed! Extremely helpful information specially the last part 🙂 I
care for such info much. I was seeking this certain info for a very long
time. Thank you and good luck.
Can you be more specific about the content of your article? After reading it, I still have some doubts. Hope you can help me. https://accounts.binance.com/hu/register-person?ref=FIHEGIZ8
priligy (dapoxetine) A Representative SIRT1 immunreactivity in control, PCOS, resveratrol, metformin and metformin resveratrol groups
Oh my goodness! Amazing article dude! Thank you so much, However I am having troubles with your RSS.
I don’t understand the reason why I cannot subscribe to it.
Is there anybody else getting the same RSS issues? Anyone
that knows the solution can you kindly respond? Thanx!!
Thank you, I’ve recently been searching for info approximately this subject for
a while and yours is the greatest I have came upon till now.
But, what concerning the bottom line? Are you certain in regards to the source?
Usually I do not read post on blogs, but I wish to say that this
write-up very forced me to check out and do so! Your writing
taste has been amazed me. Thank you, very nice article.
I like the helpful information you provide for your articles.
I will bookmark your blog and take a look
at again here regularly. I’m somewhat sure I’ll be informed many new stuff right here!
Best of luck for the following!